West Pharmaceutical Services Inc

WST
As of the close on Sep 25, 2026
Price
$370.44
Market cap
$26.1B
P/E (diluted TTM)
47.4
EPS (TTM)
$7.81
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How West Pharmaceutical Services Inc Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: West Pharmaceutical Services Inc — 10-Q filed Jul 23, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 18 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 14, 2026.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Purchases & sales (open market or private)

SecurityCodePriceFiling
2026-04-27Winters Chad · VP, Chief Accounting OfficerCommon StockS — Open market or private sale−896300.67SEC filing
2026-04-27Favorite Annette F · Sr. VP & Chief HR OfficerCommon StockS — Open market or private sale−2,817305.20SEC filing
2024-10-29Witherspoon Charles · VP & TreasurerCommon StockS — Open market or private sale−478310.40SEC filing
2024-10-29Witherspoon Charles · VP & TreasurerCommon StockS — Open market or private sale−225310.40SEC filing
2024-08-19Witherspoon Charles · VP & TreasurerCommon StockS — Open market or private sale−529300.00SEC filing
2024-08-19Witherspoon Charles · VP & TreasurerCommon StockS — Open market or private sale−500300.00SEC filing
2024-08-06Green Eric Mark · President, CEO and Board ChairCommon StockS — Open market or private sale−30,732304.71SEC filing
2024-06-12Abraham Silji · SVP, Chief Technology OfficerCommon StockS — Open market or private sale−1,800330.78SEC filing

Showing 8 of 10 rows

Grants, exercises, tax & gifts

SecurityCodeFiling
2026-05-12Campbell Shane Alden · SVP, Proprietary SegmentCommon StockM — Exercise or conversion of derivative security+474SEC filing
2026-05-12Campbell Shane Alden · SVP, Proprietary SegmentCommon StockM — Exercise or conversion of derivative security+296SEC filing
2026-05-12Campbell Shane Alden · SVP, Proprietary SegmentRst. Stock UnitM — Exercise or conversion of derivative security−296SEC filing
2026-05-12Campbell Shane Alden · SVP, Proprietary SegmentRst. Stock UnitM — Exercise or conversion of derivative security−474SEC filing
2026-05-12Campbell Shane Alden · SVP, Proprietary SegmentCommon StockF — Payment of exercise price or tax by delivering securities−84SEC filing
2026-05-12Campbell Shane Alden · SVP, Proprietary SegmentCommon StockF — Payment of exercise price or tax by delivering securities−135SEC filing
2026-05-04FRIEL ROBERT F · DirectorCommon StockA — Grant, award, or other acquisition+791SEC filing
2026-05-04Feehery William F · DirectorCommon StockA — Grant, award, or other acquisition+791SEC filing

Showing 8 of 32 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.